- Home
- OBIO vs PAYS Comparison
OBIO vs PAYS Comparison
Compare OBIO & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PAYS
- Stock Information
- Founded
- OBIO 2017
- PAYS 2001
- Country
- OBIO United States
- PAYS United States
- Employees
- OBIO N/A
- PAYS N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PAYS Business Services
- Sector
- OBIO Health Care
- PAYS Consumer Discretionary
- Exchange
- OBIO Nasdaq
- PAYS Nasdaq
- Market Cap
- OBIO 147.8M
- PAYS 125.2M
- IPO Year
- OBIO N/A
- PAYS 1998
- Fundamental
- Price
- OBIO $2.75
- PAYS $5.25
- Analyst Decision
- OBIO Strong Buy
- PAYS Strong Buy
- Analyst Count
- OBIO 4
- PAYS 4
- Target Price
- OBIO $14.00
- PAYS $7.31
- AVG Volume (30 Days)
- OBIO 339.4K
- PAYS 761.5K
- Earning Date
- OBIO 08-12-2025
- PAYS 11-04-2025
- Dividend Yield
- OBIO N/A
- PAYS N/A
- EPS Growth
- OBIO N/A
- PAYS N/A
- EPS
- OBIO N/A
- PAYS 0.12
- Revenue
- OBIO $2,944,000.00
- PAYS $68,539,381.00
- Revenue This Year
- OBIO $19.83
- PAYS $35.12
- Revenue Next Year
- OBIO $12.53
- PAYS $20.99
- P/E Ratio
- OBIO N/A
- PAYS $43.76
- Revenue Growth
- OBIO 41.61
- PAYS 27.84
- 52 Week Low
- OBIO $2.37
- PAYS $1.80
- 52 Week High
- OBIO $6.50
- PAYS $8.88
- Technical
- Relative Strength Index (RSI)
- OBIO 50.09
- PAYS 37.87
- Support Level
- OBIO $2.65
- PAYS $4.94
- Resistance Level
- OBIO $3.08
- PAYS $5.54
- Average True Range (ATR)
- OBIO 0.16
- PAYS 0.24
- MACD
- OBIO 0.03
- PAYS 0.05
- Stochastic Oscillator
- OBIO 52.86
- PAYS 48.44
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.